儿童银屑病的治疗

摘要/Abstract

摘要： 儿童银屑病不同于成人银屑病，常有瘙痒，皮损相对较薄，鳞屑少。在荷兰［1］、新加坡［1］、中国［２］、瑞典［３］、美国［４］等地进行的大规模回顾性及队列研究显示，儿童银屑病斑块型是最常见的类型，点滴型次之，红皮病性、关节病性、局限性及泛发性脓疱性银屑病较为少见，儿童滴状银屑病发病率高于成人。四肢是最易受累的部位，其次是头皮。大部分患儿皮肤受累面积小于全身面积的5%，因此，大多数儿童银屑病患者局部用药就能控制病情，常作为一线用药，其中糖皮质激素和维生素D3衍生物是首选用药，钙调磷酸酶抑制剂常用于面部及皱褶部位……

关键词: 银屑病, 儿童, 治疗

Key words: Therapy.

舒丹晋红中. 儿童银屑病的治疗[J]. 中华皮肤科杂志, 2013, 46(3): 210-212.

SHU Dan. Treatment of psoriasis in children[J]. Chinese Journal of Dermatology, 2013, 46(3): 210-212.

参考文献

1. Chiam LY, de Jager ME, Giam YC, et al. Juvenile psoriasis in European and Asian children: similarities and differences. Br J Dermatol. 2011; 164(5):1101-1103. 2. Fan X, Xiao FL, Yang S, et al. Childhood psoriasis: a study of 277 patients from China. J Eur Acad Dermatol Venereol. 2007; 21(6):762-765. 3. G?nemo A, Wahlgren CF, Svensson ?. Quality of life and clinical features in Swedish children with psoriasis. Pediatr Dermatol. 2011; 28(4):375-379. 4. Tollefson MM, Crowson CS, McEvoy MT, et al. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010; 62(6):979-987. 5. Lebwohl M. The role of salicylic acid in the treatment of psoriasis. Int J Dermatol ,1999,38(1):16-24 6. Alora-Palli MB, Perkins AC, Van Cott A, et al. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream. Am J Clin Dermatol. 2010;11(4):275-283. 7. Zvulunov A, Anisfeld A, Metzker A. Efficacy of short-contact therapy with dithranol in childhood psoriasis. Int J Dermatol. 1994; 33(11):808-810. 8. Cornell RC. Clinical trials of topical corticosteroids in psoriasis:correlations with the vasoconstrictor assay. Int J Dermatol.1992;31(Suppl 1):38-40. 9. Feldman SR. Tachyphylaxis to topical corticosteroids: the more you use them, the less they work. Clin Dermatol 2006; 24(3): 229–230. 10. Darley CR, Cunliffe WJ, Green CM, et al. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris. Br J Dermatol 1996;135(3):390-393. 11. Park SB, Suh DH, Youn JI. A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis. Pediatr Dermatol. 1999; 16(4):321-325. 12. Molin L, Cutler TP, Helander I, et al. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.Br J Dermatol. 1997; 136(1):89-93. 13. Dilurio L, Campione E, Patern EJ, et a1. Childhood nail psoriasis：a useful treatment with tazurotene 0.05％. Pediatr Dermatol 2007;24(3):332-333. 14. Brune A, Miller DW, Lin P, et al. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol. 2007; 24(1):76-80. 15. Mansouri P, Farshi S. Pimecrolimus 1 percent cream in the treatment of psoriasis in a child. Dermatol Online J 2006;12(2):7. 16. Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen ultraviolet A: A cohort study. J Invest Dermatol 2003;121(2):252-258. 17. Collin B, Vani A, Ogboli M, Moss C. Methotrexate treatment in 13 children with severe plaque psoriasis. Clin Exp Dermatol. 2009;34(3):295-298. 18. Inderjeet Kaur, Sunil Dogra, D.N.B., et al. Systemic Methotrexate Treatment in Childhood Psoriasis: Further Experience in 24 Children from India.Pediatric Dermatology. 2008; 25(2): 184–188. 19. Lee JY. Severe 20-nail psoriasis successfully treated by low dose methotrexate. Dermatol Online J, 2009;l5(11):8. 20. Lahdenne P, Rapola J, Ylijoki H, et al. Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy.J Rheumatol.2002;29(11):2442-2445. 21. Kalb RE, Strober B, Weinstein G, et al. Methotrexate and psoriasis:2009 National Psoriasis Foundation consensus conference. J Am Acad Dermatol.2009;60(5):824-837. 22. Kopp T, Karlhofer F, Szépfalusi Z,et al. Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis Br J Dermatol. 2004;151(4):912-916. 23. Kim HS, Kim GM, Kim SY.Two-stage therapy for childhood generalized pustular psoriasis: low-dose cyclosporin for induction and maintenance with acitretin/narrowband ultraviolet B phototherapy. Pediatr Dermatol. 2006;23(3):306-308. 24. Pereira TM, Vieira AP, Fernandes JC,et al. Cyclosporin A treatment in severe childhood psoriasis. Eur Acad Dermatol Venereol 2006; 20(6):651-656. 25. Harper JI, Ahmed I, Barclay G ,et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol. 2000; 142(1): 52–58. 26. Mahe E, Bodemer C, Pruszkowski A, et al. Cyclosporine in childhood psoriasis. Arch Dermatol 2001;137(11):1532-1533. 27. Patel AM, Moreland LW. Certolizumab pegol: a new biologic targeting rheumatoid arthritis. Expert Rev Clin Immunol. 2010; 6(6):855-866. 28. Paller AS, Siegfried EC, Langley RG, et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl Jmed. 2008;358(3):241-251. 29. Hawrot AC, Metry DW, Theos AJ, et a1.Etanercept for psoriasis in the pediatric population: experience in nine patients. Pediatr Dermatol.2006;23(1):67-71. 30. Fabrizi G, Guerriero C, Pagliarello C.Etanercept in infants: suberythrodermic, recalcitrant psoriasis in a 22 month-old child successfully treated with etanercept. Eur J Dermatol. 2007;17(3):245. 31. Lovell DJ, Giannini EH, Reiff A, et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum. 2003; 48(1):218-26. 32. Lovell DJ, Reiff A, Ilowite NT, et al: Safety and ef?cacy of up to eight years with continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2008; 58(5):1496-1504. 33. Menter MA, Cush JM. Successful treatment of pediatric psoriasis with in?iximab. Pediatr Dermatol.2004; 21(1):87-88. 34. Pereira TM, Vieira AP, Fernandes JC, et al. Anti-TNF alpha therapy in childhood pustular psoriasis. Dermatology.2006; 213(4):350-352. 35. Farnsworth NN, George SJ, Hsu S. Successful use of in?iximab following a failed course of etanercept in a pediatric patient. Dermatol Online J.2005; 11(3):11. 36. Hyams JS, Lere MS, Grif?ths A, et al: Long-term outcome of maintenance in?iximab therapy in children with Crohn’s disease. In?amm Bowel Dis.2009; 15(6):816-822. 37. Parslew R, Trauslen J. Efficacy and local safety of a calcipotriol/betamethasone dipropionate ointment in elderly patientswith psoriasis vulgaris. Eur J Dermatol 2005; 15(1):37-39. 38. Osmancevic A, Landin-Wilhelmsen K, Larko O, et al. UVB therapy increases 25(OH) vitamin D syntheses in postmenopausal women with psoriasis. Photodermatol Photoimmunol Photomed 2007; 23(5):172-178. 39. Fairris GM, Dewhurst AG, White JE, Campbell MJ. Methotrexate dosage in patients aged over 50 with psoriasis. BMJ 1989; 298: 801-802. 40. Prodanovich S, Ma F, Taylor JR, et al. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 2005; 52(2):262-267. 41. Gottlieb AB, Boehncke WH, Darif M. Safety and efficacy of alefacept in elderly and other special populations. J Drugs Dermatol 2005; 4(6):718-724. 42. Militello G, Xia A, Stevens SR, et al. Etanercept for the treatment of psoriasis in the elderly. J Am Acad Dermatol 2006; 55(3):517-519. 43. Grozdev IS, Van Voorhees AS, Gottlieb AB, et al. Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2011; 65(3):537-545.

[1]	徐教生向欣徐子刚邢嬛马琳. 儿童原发性皮肤骨瘤11例临床分析[J]. 中华皮肤科杂志, 2019, 52(8): 525-528.
[2]	梁源刘玲玲王珊赵作涛马琳向欣顾恒陈崑王华易红陈谨萍张金桃姚志荣郭一峰陈戟程颖朱学骏. 0.03%他克莫司软膏长期间歇维持治疗儿童特应性皮炎的多中心随机对照临床研究[J]. 中华皮肤科杂志, 2019, 52(8): 519-524.
[3]	路坦王珊王榴慧李萍舒虹申春平吴瑶罗珍缪丽敏王红兵焦磊田晶彭晓霞赵牧童刘盈聂晓璐马琳何黎. 一种含青刺果油等提取物的润肤剂改善儿童特应性皮炎缓解期临床症状的多中心、随机、平行对照临床研究[J]. 中华皮肤科杂志, 2019, 52(8): 537-541.
[4]	苏蓓蓓甘泉甘才斌. 二甲双胍对银屑病样小鼠模型皮损炎症状态及磷酸化Stat3蛋白表达的影响[J]. 中华皮肤科杂志, 2019, 52(7): 475-480.
[5]	卢旭亚徐强李品川张朝晖. 下肢痛性溃疡诊疗进展[J]. 中华皮肤科杂志, 2019, 52(7): 510-514.
[6]	陈怡雯苏婷苏忠兰. 银屑病与STAT3[J]. 中华皮肤科杂志, 2019, 52(7): 502-505.
[7]	覃慧郑捷. 鞘氨醇1-磷酸盐受体拮抗剂（FTY720）抑制皮肤中分泌白细胞介素17的γδT细胞治疗银屑病的机制研究[J]. 中华皮肤科杂志, 2019, 52(6): 395-400.
[8]	王丽玮罗玲玲崔盘根李岷. 肠道菌群与银屑病关系的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 357-360.
[9]	余丽娟吕中法. JAK抑制剂治疗斑秃的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 343-346.
[10]	胡煜陈敏顾恒. microRNA和lncRNA在银屑病中的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 350-353.
[11]	潘家旭周婧. 核因子κB信号通路在银屑病中的研究进展[J]. 中华皮肤科杂志, 2019, 52(5): 361-363.
[12]	周园陈韡王大光. 钳形甲的治疗进展[J]. 中华皮肤科杂志, 2019, 52(5): 364-367.
[13]	曾菁莘田歆朱慧兰张锡宝林玲张丽丹刘炜钰罗权. 微小RNA-148a-3p在寻常型银屑病患者外周血CD4⁺ T淋巴细胞中的表达及临床意义[J]. 中华皮肤科杂志, 2019, 52(4): 231-235.
[14]	罗金成陈曙光刘文英徐艳宋志强. 自体全血注射对自体血清皮肤试验阳性的难治性慢性自发性荨麻疹患者嗜碱性粒细胞FcεRⅠ与CD63表达的影响[J]. 中华皮肤科杂志, 2019, 52(4): 241-247.
[15]	雷杰豪樊奇敏陈荣许爱娥. 白癜风患者窄谱中波紫外线治疗效果与光疗反应的关系及相关因素分析[J]. 中华皮肤科杂志, 2019, 52(4): 259-262.